Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Taysha Gene Therapies

Taysha Gene Therapies Added to the Nasdaq Biotechnology Index
From Taysha Gene Therapies
Via Business Wire
Tickers TSHA
Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
From Taysha Gene Therapies
Via Business Wire
Tickers TSHA
Taysha Gene Therapies Announces Publication of Positive Proof-of-Concept Preclinical Data for an AAV-mediated UBE3A Gene Replacement Approach Demonstrating Therapeutic Potential for The Treatment of Angelman Syndrome in the Journal JCI Insight
From Taysha Gene Therapies
Via Business Wire
Tickers TSHA
Taysha Announces Exclusive Option from UTSW to License Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program for CLN7 Disease, a Research Collaboration with UTSW to Develop Next-Generation Construct for CLN7 and a Grant Award to Batten Hope
From Taysha Gene Therapies
Via Business Wire
Tickers TSHA
Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
From Taysha Gene Therapies
Via Business Wire
Tickers TSHA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.